Journal of International Reproductive Health/Family Planning ›› 2025, Vol. 44 ›› Issue (3): 192-200.doi: 10.12280/gjszjk.20240629
• Original Article • Previous Articles Next Articles
WANG Heng-yang, HU Rong, FAN Wei, ZHANG Li-hong, ZHANG Zhi-gang()
Received:
2024-12-25
Published:
2025-05-15
Online:
2025-06-04
Contact:
ZHANG Zhi-gang, E-mail: WANG Heng-yang, HU Rong, FAN Wei, ZHANG Li-hong, ZHANG Zhi-gang. The Effectiveness of Four Commonly Used Oral Nutraceuticals in Improving the Sperm Quality in Male Infertility: A Network Meta-Analysis[J]. Journal of International Reproductive Health/Family Planning, 2025, 44(3): 192-200.
Add to citation manager EndNote|Ris|BibTeX
文献 | 国家 | 样本量(例) | 干预措施 | 相关结局 | 年龄(岁) | 干预时间 | |||
---|---|---|---|---|---|---|---|---|---|
试验组 | 对照组 | 试验组 | 对照组 | 试验组 | 对照组 | ||||
Montanino Oliva等[ | 意大利 | 43 | 43 | 肌醇栓剂 | 安慰剂栓剂 | ②⑤ | 25~39 | 25~39 | 直到妊娠 |
Maghsoumi-Norouzabad等[ | 伊朗 | 43 | 43 | 维生素D 4 000 IU/d | 安慰剂 4 000 IU/d | ②③④⑤ | 35.13±5.51 | 34.44±5.07 | 12周 |
Sabetian等[ | 伊朗 | 63 | 61 | 维生素E 400 IU/d | 安慰剂 400 IU/d | ②③⑤ | 35.76±7.24 | 36.72±6.61 | 8周 |
Capece等[ | 意大利 | 28 | 28 | 肌醇1 000 mg, 1次/d | 安慰剂1 000 mg,1次/d | ①②③ | 28.4±6.6 | 28.8±5.2 | 12周 |
Calogero等[ | 意大利 | 98 | 96 | 肌醇2 000 mg, 2次/d | 安慰剂2 000 mg,1次/d | ①② | 28 | 28 | 12周 |
Eslamian等[ | 加拿大 | 15 | 16 | 维生素E 600 IU/d | 安慰剂600 IU/d | ①②③④⑤ | 32.80±4.13 | 33.04±4.08 | 12周 |
Ener等[ | 土耳其 | 22 | 23 | 维生素E 300 mg,2次/d | 安慰剂 300 mg,2次/d | ④ | 26.5±5.0 | 25.2±4.3 | 12周 |
Safarinejad等[ | 伊朗 | 101 | 102 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ②③④⑤ | 31 | 32 | 26周 |
Safarinejad[ | 伊朗 | 98 | 96 | CoQ10 300 mg/d | 安慰剂 300 mg/d | ②③④⑤ | 28±9 | 28±10 | 26周 |
Nadjarzadeh等[ | 伊朗 | 23 | 24 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ①②③ | 34.17±4.52 | 34.67±6.69 | 12周 |
Balercia等[ | 意大利 | 28 | 27 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ①② | 32 | 32 | 24周 |
Blomberg Jensen等[ | 丹麦 | 133 | 136 | 维生素D 1 400 IU+钙500 mg/d | 安慰剂 500 mg/d | ①②③④⑤ | 34.3±6.2 | 35.2±6.8 | 24周 |
Amini等[ | 伊朗 | 31 | 31 | 维生素 D 50 000 IU/周 | 安慰剂 50 000 IU/周 | ①③⑤ | 34.37±4.83 | 34.86±4.65 | 12周 |
文献 | 国家 | 样本量(例) | 干预措施 | 相关结局 | 年龄(岁) | 干预时间 | |||
---|---|---|---|---|---|---|---|---|---|
试验组 | 对照组 | 试验组 | 对照组 | 试验组 | 对照组 | ||||
Montanino Oliva等[ | 意大利 | 43 | 43 | 肌醇栓剂 | 安慰剂栓剂 | ②⑤ | 25~39 | 25~39 | 直到妊娠 |
Maghsoumi-Norouzabad等[ | 伊朗 | 43 | 43 | 维生素D 4 000 IU/d | 安慰剂 4 000 IU/d | ②③④⑤ | 35.13±5.51 | 34.44±5.07 | 12周 |
Sabetian等[ | 伊朗 | 63 | 61 | 维生素E 400 IU/d | 安慰剂 400 IU/d | ②③⑤ | 35.76±7.24 | 36.72±6.61 | 8周 |
Capece等[ | 意大利 | 28 | 28 | 肌醇1 000 mg, 1次/d | 安慰剂1 000 mg,1次/d | ①②③ | 28.4±6.6 | 28.8±5.2 | 12周 |
Calogero等[ | 意大利 | 98 | 96 | 肌醇2 000 mg, 2次/d | 安慰剂2 000 mg,1次/d | ①② | 28 | 28 | 12周 |
Eslamian等[ | 加拿大 | 15 | 16 | 维生素E 600 IU/d | 安慰剂600 IU/d | ①②③④⑤ | 32.80±4.13 | 33.04±4.08 | 12周 |
Ener等[ | 土耳其 | 22 | 23 | 维生素E 300 mg,2次/d | 安慰剂 300 mg,2次/d | ④ | 26.5±5.0 | 25.2±4.3 | 12周 |
Safarinejad等[ | 伊朗 | 101 | 102 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ②③④⑤ | 31 | 32 | 26周 |
Safarinejad[ | 伊朗 | 98 | 96 | CoQ10 300 mg/d | 安慰剂 300 mg/d | ②③④⑤ | 28±9 | 28±10 | 26周 |
Nadjarzadeh等[ | 伊朗 | 23 | 24 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ①②③ | 34.17±4.52 | 34.67±6.69 | 12周 |
Balercia等[ | 意大利 | 28 | 27 | CoQ10 200 mg/d | 安慰剂 200 mg/d | ①② | 32 | 32 | 24周 |
Blomberg Jensen等[ | 丹麦 | 133 | 136 | 维生素D 1 400 IU+钙500 mg/d | 安慰剂 500 mg/d | ①②③④⑤ | 34.3±6.2 | 35.2±6.8 | 24周 |
Amini等[ | 伊朗 | 31 | 31 | 维生素 D 50 000 IU/周 | 安慰剂 50 000 IU/周 | ①③⑤ | 34.37±4.83 | 34.86±4.65 | 12周 |
相关结局 | 干预方法 | 纳入研究(篇) | 异质性检验 | 效应模型 | MD(95%CI) | P | |
---|---|---|---|---|---|---|---|
I2 | P | ||||||
精子浓度 | 肌醇 | 2[ | 89% | 0.003 | 随机 | 3.86(0.25~7.47) | 0.04 |
CoQ10 | 2[ | 0% | 0.87 | 固定 | -0.04(-0.43~0.34) | 0.83 | |
精子活力 | 肌醇 | 3[ | 72% | 0.03 | 随机 | 5.07(2.01~8.13) | 0.001 |
维生素E | 2[ | 0% | 0.85 | 固定 | 0.35(-1.96~2.66) | 0.77 | |
CoQ10 | 4[ | 98% | <0.000 1 | 随机 | 6.21(1.75~10.68) | 0.006 | |
精子形态 | 维生素E | 2[ | 0% | 0.85 | 固定 | -0.13(-0.59~0.34) | 0.59 |
维生素D | 2[ | 0% | 0.53 | 固定 | 0.04(-0.43~0.52) | 0.86 | |
CoQ10 | 3[ | 47% | 0.15 | 固定 | 1.95(1.41~2.50) | <0.000 1 | |
精子数量 | 维生素E | 2[ | 84% | 0.01 | 随机 | 7.73(-11.22~26.68) | 0.42 |
CoQ10 | 2[ | 89% | 0.003 | 随机 | 13.82(5.89~21.76) | 0.000 6 | |
精液体积 | 维生素E | 2[ | 0% | 0.71 | 固定 | -0.05(-0.24~0.15) | 0.64 |
维生素D | 2[ | 0% | 0.93 | 固定 | -0.23(-0.84~0.37) | 0.45 | |
CoQ10 | 2[ | 0% | 0.75 | 固定 | -0.05(-0.35~0.25) | 0.73 |
相关结局 | 干预方法 | 纳入研究(篇) | 异质性检验 | 效应模型 | MD(95%CI) | P | |
---|---|---|---|---|---|---|---|
I2 | P | ||||||
精子浓度 | 肌醇 | 2[ | 89% | 0.003 | 随机 | 3.86(0.25~7.47) | 0.04 |
CoQ10 | 2[ | 0% | 0.87 | 固定 | -0.04(-0.43~0.34) | 0.83 | |
精子活力 | 肌醇 | 3[ | 72% | 0.03 | 随机 | 5.07(2.01~8.13) | 0.001 |
维生素E | 2[ | 0% | 0.85 | 固定 | 0.35(-1.96~2.66) | 0.77 | |
CoQ10 | 4[ | 98% | <0.000 1 | 随机 | 6.21(1.75~10.68) | 0.006 | |
精子形态 | 维生素E | 2[ | 0% | 0.85 | 固定 | -0.13(-0.59~0.34) | 0.59 |
维生素D | 2[ | 0% | 0.53 | 固定 | 0.04(-0.43~0.52) | 0.86 | |
CoQ10 | 3[ | 47% | 0.15 | 固定 | 1.95(1.41~2.50) | <0.000 1 | |
精子数量 | 维生素E | 2[ | 84% | 0.01 | 随机 | 7.73(-11.22~26.68) | 0.42 |
CoQ10 | 2[ | 89% | 0.003 | 随机 | 13.82(5.89~21.76) | 0.000 6 | |
精液体积 | 维生素E | 2[ | 0% | 0.71 | 固定 | -0.05(-0.24~0.15) | 0.64 |
维生素D | 2[ | 0% | 0.93 | 固定 | -0.23(-0.84~0.37) | 0.45 | |
CoQ10 | 2[ | 0% | 0.75 | 固定 | -0.05(-0.35~0.25) | 0.73 |
干预措施 | 精子浓度 | 精子活力 | 精子形态 | 精子数量 | 精液体积 | |||||
---|---|---|---|---|---|---|---|---|---|---|
SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | |
安慰剂 | 46.7 | 3.7 | 28.5 | 4.6 | 57.7 | 2.7 | 32.7 | 3.7 | 46.9 | 3.1 |
维生素E | 46.9 | 3.7 | 31.0 | 4.5 | 45.2 | 3.2 | 63.5 | 2.5 | 32.5 | 3.7 |
CoQ10 | 42.4 | 3.9 | 82.3 | 1.9 | 100.0 | 1.0 | 88.7 | 1.5 | 32.9 | 3.7 |
维生素D | 29.5 | 4.5 | 75.0 | 2.2 | 37.5 | 3.5 | 39.9 | 7.8 | 38.2 | 3.5 |
肌醇 | 91.1 | 1.4 | 78.6 | 2.1 | - | - | - | - | - | - |
维生素D+钙 | 43.4 | 3.8 | 4.6 | 5.8 | 9.6 | 4.6 | 25.3 | 6.5 | 99.4 | 1.0 |
干预措施 | 精子浓度 | 精子活力 | 精子形态 | 精子数量 | 精液体积 | |||||
---|---|---|---|---|---|---|---|---|---|---|
SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | SUCRA(%) | 等级 | |
安慰剂 | 46.7 | 3.7 | 28.5 | 4.6 | 57.7 | 2.7 | 32.7 | 3.7 | 46.9 | 3.1 |
维生素E | 46.9 | 3.7 | 31.0 | 4.5 | 45.2 | 3.2 | 63.5 | 2.5 | 32.5 | 3.7 |
CoQ10 | 42.4 | 3.9 | 82.3 | 1.9 | 100.0 | 1.0 | 88.7 | 1.5 | 32.9 | 3.7 |
维生素D | 29.5 | 4.5 | 75.0 | 2.2 | 37.5 | 3.5 | 39.9 | 7.8 | 38.2 | 3.5 |
肌醇 | 91.1 | 1.4 | 78.6 | 2.1 | - | - | - | - | - | - |
维生素D+钙 | 43.4 | 3.8 | 4.6 | 5.8 | 9.6 | 4.6 | 25.3 | 6.5 | 99.4 | 1.0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 肌醇 | 维生素D+钙 |
---|---|---|---|---|---|---|
安慰剂 | 0 | |||||
维生素E | -0.60(-4.73~4.61) | 0 | ||||
CoQ10 | -0.06(-7.73~6.17) | -0.54(-8.76~7.68) | 0 | |||
维生素D | -2.12(-10.11~5.87) | -2.06(-11.31~7.19) | -1.52(-11.99~8.95) | 0 | ||
肌醇 | 3.88(0.59~7.17)* | 3.94(-1.77~9.65) | 4.48(-3.04~12.01) | 6.00(-2.64~14.64) | 0 | |
维生素D+钙 | -0.05(-7.58~6.58) | -0.44(-8.91~8.03) | 0.10(-9.69~9.89) | 1.62(-9.05~12.29) | -4.38(-12.19~3.42) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 肌醇 | 维生素D+钙 |
---|---|---|---|---|---|---|
安慰剂 | 0 | |||||
维生素E | -0.60(-4.73~4.61) | 0 | ||||
CoQ10 | -0.06(-7.73~6.17) | -0.54(-8.76~7.68) | 0 | |||
维生素D | -2.12(-10.11~5.87) | -2.06(-11.31~7.19) | -1.52(-11.99~8.95) | 0 | ||
肌醇 | 3.88(0.59~7.17)* | 3.94(-1.77~9.65) | 4.48(-3.04~12.01) | 6.00(-2.64~14.64) | 0 | |
维生素D+钙 | -0.05(-7.58~6.58) | -0.44(-8.91~8.03) | 0.10(-9.69~9.89) | 1.62(-9.05~12.29) | -4.38(-12.19~3.42) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 肌醇 | 维生素D+钙 |
---|---|---|---|---|---|---|
安慰剂 | 0 | |||||
维生素E | 0.26(-4.35~4.68) | 0 | ||||
CoQ10 | 6.45(3.23~9.67)* | 6.20(0.58~11.81)* | 0 | |||
维生素D | 5.86(-0.53~12.25) | 5.60(-2.27~13.48) | -0.59(-7.75~6.56) | 0 | ||
肌醇 | 5.99(1.91~10.08)* | 5.74(-0.42~11.90) | -0.46(-5.69~4.77) | 0.13(-7.45~7.72) | 0 | |
维生素D+钙 | -4.00(-9.57~1.57) | -4.26(-11.48~2.97) | -10.45(-16.88~-4.02)* | -9.86(-18.33~-1.39)* | -9.99(-16.90~-3.09)* | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 肌醇 | 维生素D+钙 |
---|---|---|---|---|---|---|
安慰剂 | 0 | |||||
维生素E | 0.26(-4.35~4.68) | 0 | ||||
CoQ10 | 6.45(3.23~9.67)* | 6.20(0.58~11.81)* | 0 | |||
维生素D | 5.86(-0.53~12.25) | 5.60(-2.27~13.48) | -0.59(-7.75~6.56) | 0 | ||
肌醇 | 5.99(1.91~10.08)* | 5.74(-0.42~11.90) | -0.46(-5.69~4.77) | 0.13(-7.45~7.72) | 0 | |
维生素D+钙 | -4.00(-9.57~1.57) | -4.26(-11.48~2.97) | -10.45(-16.88~-4.02)* | -9.86(-18.33~-1.39)* | -9.99(-16.90~-3.09)* | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | -0.14(-0.84~0.57) | 0 | |||
CoQ10 | 1.98(1.29~2.68)* | 2.12(1.12~3.12)* | 0 | ||
维生素D | -0.26(-1.40~0.88) | -0.12(-1.46~1.22) | -2.24(-3.58~-0.91)* | 0 | |
维生素D+钙 | -0.70(-1.29~-0.11)* | -0.56(-1.48~0.35) | -2.68(-3.59~-1.77)* | -0.44(-1.72~0.84) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | -0.14(-0.84~0.57) | 0 | |||
CoQ10 | 1.98(1.29~2.68)* | 2.12(1.12~3.12)* | 0 | ||
维生素D | -0.26(-1.40~0.88) | -0.12(-1.46~1.22) | -2.24(-3.58~-0.91)* | 0 | |
维生素D+钙 | -0.70(-1.29~-0.11)* | -0.56(-1.48~0.35) | -2.68(-3.59~-1.77)* | -0.44(-1.72~0.84) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | 6.62(-7.97~21.21) | 0 | |||
CoQ10 | 13.84(1.49~26.19)* | 7.22(-11.89~26.32) | 0 | ||
维生素D | 0.84(-16.82~18.50) | -5.78(-28.69~17.12) | -13.00(-34.55~8.55) | 0 | |
维生素D+钙 | -5.00(-29.38~19.38) | -11.62(-40.03~16.79) | -18.84(-46.17~8.49) | -5.84(-35.94~24.26) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | 6.62(-7.97~21.21) | 0 | |||
CoQ10 | 13.84(1.49~26.19)* | 7.22(-11.89~26.32) | 0 | ||
维生素D | 0.84(-16.82~18.50) | -5.78(-28.69~17.12) | -13.00(-34.55~8.55) | 0 | |
维生素D+钙 | -5.00(-29.38~19.38) | -11.62(-40.03~16.79) | -18.84(-46.17~8.49) | -5.84(-35.94~24.26) | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | -0.05(-0.24~0.15) | 0 | |||
CoQ10 | -0.05(-0.35~0.25) | -0.01(-0.36~0.35) | 0 | ||
维生素D | -0.03(-0.43~0.37) | 0.01(-0.43~0.46) | 0.02(-0.48~0.52) | 0 | |
维生素D+钙 | 0.40(0.30~0.46)* | 0.45(0.23~0.66)* | 0.45(0.14~0.77)* | 0.43(0.02~0.84)* | 0 |
干预措施 | 安慰剂 | 维生素E | CoQ10 | 维生素D | 维生素D+钙 |
---|---|---|---|---|---|
安慰剂 | 0 | ||||
维生素E | -0.05(-0.24~0.15) | 0 | |||
CoQ10 | -0.05(-0.35~0.25) | -0.01(-0.36~0.35) | 0 | ||
维生素D | -0.03(-0.43~0.37) | 0.01(-0.43~0.46) | 0.02(-0.48~0.52) | 0 | |
维生素D+钙 | 0.40(0.30~0.46)* | 0.45(0.23~0.66)* | 0.45(0.14~0.77)* | 0.43(0.02~0.84)* | 0 |
[1] | Agarwal A, Mulgund A, Hamada A, et al. A unique view on male infertility around the globe[J]. Reprod Biol Endocrinol, 2015, 13:37. doi: 10.1186/s12958-015-0032-1. |
[2] | Illiano E, Trama F, Zucchi A, et al. Resveratrol-Based Multivitamin Supplement Increases Sperm Concentration and Motility in Idiopathic Male Infertility: A Pilot Clinical Study[J]. J Clin Med, 2020, 9(12):4017. doi: 10.3390/jcm9124017. |
[3] |
Colpi GM, Francavilla S, Haidl G, et al. European Academy of Andrology guideline Management of oligo-astheno-teratozoospermia[J]. Andrology, 2018, 6(4):513-524. doi: 10.1111/andr.12502.
pmid: 30134082 |
[4] | 马婧, 韩瑞钰, 梅雪昂, 等. 胰岛素抵抗指数与男性生殖激素水平及精液参数的相关性分析[J]. 中华男科学杂志, 2018, 24(8):695-699. doi: 10.13263/j.cnki.nja.2018.08.005. |
[5] | Lotti F, Marchiani S, Corona G, et al. Metabolic Syndrome and Reproduction[J]. Int J Mol Sci, 2021, 22(4):1988. doi: 10.3390/ijms22041988. |
[6] |
Sangouni AA, Taghdir M, Mirahmadi J, et al. Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial[J]. Nutr J, 2022, 21(1):62. doi: 10.1186/s12937-022-00816-7.
pmid: 36192751 |
[7] | Lepore E, Lauretta R, Bianchini M, et al. Inositols Depletion and Resistance: Principal Mechanisms and Therapeutic Strategies[J]. Int J Mol Sci, 2021, 22(13):6796. doi: 10.3390/ijms22136796. |
[8] | Yoo JY, Yum KS. Effect of Coenzyme Q10 on Insulin Resistance in Korean Patients with Prediabetes: A Pilot Single-Center, Randomized, Double-Blind, Placebo-Controlled Study[J]. Biomed Res Int, 2018, 2018:1613247. doi: 10.1155/2018/1613247. |
[9] | Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men[J]. Diabet Med, 2009, 26(1):19-27. doi: 10.1111/j.1464-5491.2008.02636.x. |
[10] | Su L, Qu H, Cao Y, et al. Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials[J]. Adv Nutr, 2022, 13(2):586-594. doi: 10.1093/advances/nmab127. |
[11] | 庞霁芸, 侯苇, 农玉翔, 等. 人工智能在精子质量分析与精子优选中的应用[J]. 四川大学学报(医学版), 2024, 55(5):1322-1328. doi: 10.12182/20240960603. |
[12] | Marotta N, Demeco A, Moggio L, et al. Comparative effectiveness of breathing exercises in patients with chronic obstructive pulmonary disease[J]. Complement Ther Clin Pract, 2020, 41:101260. doi: 10.1016/j.ctcp.2020.101260. |
[13] | Montanino Oliva M, Buonomo G, Carra MC, et al. Myo-inositol impact on sperm motility in vagina and evaluation of its effects on foetal development[J]. Eur Rev Med Pharmacol Sci, 2020, 24(5):2704-2709. doi: 10.26355/eurrev_202003_20540. |
[14] | Maghsoumi-Norouzabad L, Zare Javid A, Mansoori A, et al. Vitamin D3 Supplementation Effects on Spermatogram and Oxidative Stress Biomarkers in Asthenozoospermia Infertile Men: a Randomized, Triple-Blind, Placebo-Controlled Clinical Trial[J]. Reprod Sci, 2022, 29(3):823-835. doi: 10.1007/s43032-021-00769-y. |
[15] | Sabetian S, Jahromi BN, Vakili S, et al. The Effect of Oral Vitamin E on Semen Parameters and IVF Outcome: A Double-Blinded Randomized Placebo-Controlled Clinical Trial[J]. Biomed Res Int, 2021,2021:5588275. doi: 10.1155/2021/5588275. |
[16] |
Capece M, Romeo G, Ruffo A, et al. A phytotherapic approach to reduce sperm DNA fragmentation in patients with male infertility[J]. Urologia, 2017, 84(2):79-82. doi: 10.5301/uro.5000210.
pmid: 28058714 |
[17] |
Calogero AE, Gullo G, La Vignera S, et al. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study[J]. Andrology, 2015, 3(3):491-495. doi: 10.1111/andr.12025.
pmid: 25854593 |
[18] |
Eslamian G, Amirjannati N, Noori N, et al. Effects of coadministration of DHA and vitamin E on spermatogram, seminal oxidative stress, and sperm phospholipids in asthenozoospermic men: a randomized controlled trial[J]. Am J Clin Nutr, 2020, 112(3):707-719. doi: 10.1093/ajcn/nqaa124.
pmid: 32453396 |
[19] |
Ener K, Aldemir M, Isık E, et al. The impact of vitamin E supplementation on semen parameters and pregnancy rates after varicocelectomy: a randomised controlled study[J]. Andrologia, 2016, 48(7):829-834. doi: 10.1111/and.12521.
pmid: 26780969 |
[20] |
Safarinejad MR, Safarinejad S, Shafiei N, et al. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study[J]. J Urol, 2012, 188(2):526-531. doi: 10.1016/j.juro.2012.03.131.
pmid: 22704112 |
[21] |
Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men[J]. J Urol, 2009, 182(1):237-248. doi: 10.1016/j.juro.2009.02.121.
pmid: 19447425 |
[22] |
Nadjarzadeh A, Shidfar F, Amirjannati N, et al. Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomised clinical trial[J]. Andrologia, 2014, 46(2):177-183. doi: 10.1111/and.12062.
pmid: 23289958 |
[23] |
Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial[J]. Fertil Steril, 2009, 91(5):1785-1792. doi: 10.1016/j.fertnstert.2008.02.119.
pmid: 18395716 |
[24] |
Blomberg Jensen M, Lawaetz JG, Petersen JH, et al. Effects of Vitamin D Supplementation on Semen Quality, Reproductive Hormones, and Live Birth Rate: A Randomized Clinical Trial[J]. J Clin Endocrinol Metab, 2018, 103(3):870-881. doi: 10.1210/jc.2017-01656.
pmid: 29126319 |
[25] | Amini L, Mohammadbeigi R, Vafa M, et al. Evaluation of the effect of vitamin D3 supplementation on quantitative and qualitative parameters of spermograms and hormones in infertile men: A Randomized controlled trial[J]. Complement Ther Med, 2020, 53:102529. doi: 10.1016/j.ctim.2020.102529. |
[26] | De Luca MN, Colone M, Gambioli R, et al. Oxidative Stress and Male Fertility: Role of Antioxidants and Inositols[J]. Antioxidants(Basel), 2021, 10(8):1283. doi: 10.3390/antiox10081283. |
[27] | Aitken RJ, Drevet JR. The Importance of Oxidative Stress in Determining the Functionality of Mammalian Spermatozoa: A Two-Edged Sword[J]. Antioxidants(Basel), 2020, 9(2):111. doi: 10.3390/antiox9020111. |
[28] |
Kothari S, Thompson A, Agarwal A, et al. Free radicals: their beneficial and detrimental effects on sperm function[J]. Indian J Exp Biol, 2010, 48(5):425-435.
pmid: 20795359 |
[29] | Zańko A, Siewko K, Krętowski AJ, et al. Lifestyle, Insulin Resistance and Semen Quality as Co-Dependent Factors of Male Infertility[J]. Int J Environ Res Public Health, 2022, 20(1):732. doi: 10.3390/ijerph20010732. |
[30] |
Morrison CD, Brannigan RE. Metabolic syndrome and infertility in men[J]. Best Pract Res Clin Obstet Gynaecol, 2015, 29(4):507-515. doi: 10.1016/j.bpobgyn.2014.10.006.
pmid: 25487258 |
[31] |
Adnan E, Rahman IA, Faridin HP. Relationship between insulin resistance, metabolic syndrome components and serum uric acid[J]. Diabetes Metab Syndr, 2019, 13(3):2158-2162. doi: 10.1016/j.dsx.2019.04.001.
pmid: 31235151 |
[32] | 张国忠, 胡艳梅, 杨宗富. 肌醇治疗不育男性有效性的Meta分析[J]. 中国性科学, 2021, 30(11):5-8. doi: 10.3969/j.issn.1672-1993.2021.11.002. |
[33] | Condorelli RA, La Vignera S, Mongioì LM, et al. Myo-inositol as a male fertility molecule: speed them up![J]. Eur Rev Med Pharmacol Sci, 2017, 21(Suppl 2):30-35. |
[34] |
Condorelli RA, La Vignera S, Bellanca S, et al. Myoinositol: does it improve sperm mitochondrial function and sperm motility?[J]. Urology, 2012, 79(6):1290-1295. doi: 10.1016/j.urology.2012.03.005.
pmid: 22656408 |
[35] | 杨明根, 郑周达, 许振强, 等. 辅酶Q10治疗特发性少弱畸形精子症有效性与安全性的Meta分析[J]. 中国循证医学杂志, 2016, 16(9):1090-1096. doi: 10.7507/1672-2531.20160166. |
[36] | Groneberg DA, Kindermann B, Althammer M, et al. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells[J]. Int J Biochem Cell Biol, 2005, 37(6):1208-1218. doi: 10.1016/j.biocel.2004.11.017. |
[37] |
Gvozdjakova A, Kucharska J, Lipkova J, et al. Importance of the assessment of coenzyme Q10, alpha-tocopherol and oxidative stress for the diagnosis and therapy of infertility in men[J]. Bratisl Lek Listy, 2013, 114(11):607-609. doi: 10.4149/bll_2013_129.
pmid: 24236426 |
[38] |
Salas-Huetos A, Rosique-Esteban N, Becerra-Tomás N, et al. The Effect of Nutrients and Dietary Supplements on Sperm Quality Parameters: A Systematic Review and Meta-Analysis of Randomized Clinical Trials[J]. Adv Nutr, 2018, 9(6):833-848. doi: 10.1093/advances/nmy057.
pmid: 30462179 |
[39] | Li KP, Yang XS, Wu T. The Effect of Antioxidants on Sperm Quality Parameters and Pregnancy Rates for Idiopathic Male Infertility: A Network Meta-Analysis of Randomized Controlled Trials[J]. Front Endocrinol(Lausanne), 2022, 13:810242. doi: 10.3389/fendo.2022.810242. |
[40] |
Ramlau-Hansen CH, Moeller UK, Bonde JP, et al. Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men[J]. Fertil Steril, 2011, 95(3):1000-1004. doi: 10.1016/j.fertnstert.2010.11.002.
pmid: 21122842 |
[41] |
Abbasihormozi S, Kouhkan A, Alizadeh AR, et al. Association of vitamin D status with semen quality and reproductive hormones in Iranian subfertile men[J]. Andrology, 2017, 5(1):113-118. doi: 10.1111/andr.12280.
pmid: 27792863 |
[42] | Blomberg Jensen M, Gerner Lawaetz J, Andersson AM, et al. Vitamin D deficiency and low ionized calcium are linked with semen quality and sex steroid levels in infertile men[J]. Hum Reprod, 2016, 31(8):1875-1885. doi: 10.1093/humrep/dew152. |
[43] |
Hammoud AO, Meikle AW, Peterson CM, et al. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters[J]. Asian J Androl, 2012, 14(6):855-859. doi: 10.1038/aja.2012.77.
pmid: 23042450 |
[44] | Aquila S, Guido C, Middea E, et al. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism[J]. Reprod Biol Endocrinol, 2009, 7:140. doi: 10.1186/1477-7827-7-140. |
[45] | Yahyavi SK, Boisen IM, Cui Z, et al. Calcium and vitamin D homoeostasis in male fertility[J]. Proc Nutr Soc, 2024, 83(2):95-108. doi: 10.1017/S002966512300486X. |
[46] | 刘建家, 曾健文, 何宇, 等. 显微镜精索静脉结扎术联合维生素E改善精子DNA完整性和受孕结局的研究[J]. 生殖医学杂志, 2024, 33(4):521-525. doi: 10.3969/j.issn.1004-3845.2024.04.016. |
[47] | 孙迪, 王楠楠, 张科, 等. 维生素E在男性不育症治疗中的临床应用研究进展[J]. 中国性科学, 2018, 27(7):12-14. doi: 10.3969/j.issn.1672-1993.2018.07.002. |
[1] | MA Ying-qi, LI Jia-li, FENG Meng-zhi, SHI Bai-chao, WANG Yu, GAO Jing-shu, WU Xiao-ke. The Mechanism of Chinese Medicine Monomers and Compounds in Treatment of Polycystic Ovary Syndrome, Based on PI3K/Akt Signaling Pathway [J]. Journal of International Reproductive Health/Family Planning, 2025, 44(3): 220-226. |
[2] | JIA Sheng-xiao, SUN Miao, KUANG Hong-ying, XU Bo-ya. Advancements in Research on MicroRNAs Related to Insulin Resistance in Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2025, 44(1): 59-64. |
[3] | TIAN Dejier, FENG Xiao-ling. Possible Application of Myo-Inositol and D-Chiro-Inositol in Treatment of Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2024, 43(6): 512-517. |
[4] | ZHANG Li-hong, HU Rong, XIE Lei, XU Xiao-juan, HU Jun-ping. Effects of Novel Coronavirus Infection on Semen Indexes [J]. Journal of International Reproductive Health/Family Planning, 2023, 42(3): 231-235. |
[5] | WU Tong-tong, WANG Zhi-lian. The Relationship between PI3K/Akt Autophagy Pathway and HIF-1α in HPV16 Related Cervical Cancer [J]. Journal of International Reproductive Health/Family Planning, 2022, 41(2): 172-176. |
[6] | ZHANG Guo-zhong, ZHENG Jie, HU Yan-mei, WU Xue-yi, XIE Ping, YANG Zong-fu. Effect of Supplementary Inositol on Sperm Quality in Infertile Men [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(6): 524-528. |
[7] | YIN Lan-lan, WANG Chen-xi, MA Tian-zhong. Research Progress in In Vitro Activation Therapy for Premature Ovarian Insufficiency [J]. Journal of International Reproductive Health/Family Planning, 2020, 39(4): 319-323. |
[8] | HUANG Jia-lyu, LIN Jia-ying, CAI Ren-fei, SONG Ning, KUANG Yan-ping. Effect of Dietary Patterns on Semen Quality: A Meta-Analysis [J]. Journal of International Reproductive Health/Family Planning, 2019, 38(5): 382-388. |
[9] | ZHANG Yan-fang;HAN Yu-kun. The Progress in the Insulin Resistance and Defects in Insulin Signaling Pathways in Women with Polycystic Ovary Syndrome [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(4): 288-291. |
[10] | Lamb DJ. Semen Analysis in 21st Century Medicine: the Need for Sperm Function Testing [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 182-187. |
[11] | Menkveld R. Clinical Significance of the Low Normal SpermMorphology Value as Proposed in the Fifth Edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 168-177. |
[12] | Bjorndahl L. The Usefulness and Significance of Assessing Rapidly Progressive Spermatozoa [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 155-157. |
[13] | Joffe M. Semen Quality Analysis and the Idea of Normal Fertility [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 195-198. |
[14] | Jequier AM. Semen Analysis:A New Manual and Its Application to the Understanding of Semen and Its Pathology [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 136-138. |
[15] | Eliasson R. Semen Analysis with Regard to SpermNumber,SpermMorphology and Functional Aspects [J]. Journal of International Reproductive Health/Family Planning, 2010, 29(3): 149-154. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||